These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29094310)

  • 21. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
    Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
    J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Transplant With Cardiopulmonary Bypass: Impact of Blood Transfusion on Rejection, Function, and Late Mortality.
    Ong LP; Sachdeva A; Ramesh BC; Muse H; Wallace K; Parry G; Clark SC
    Ann Thorac Surg; 2016 Feb; 101(2):512-9. PubMed ID: 26453422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.
    Benson VS; Müllerová H; Vestbo J; Wedzicha JA; Patel A; Hurst JR;
    Respir Med; 2015 Sep; 109(9):1147-54. PubMed ID: 26166017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflux and allograft dysfunction: is there a connection?
    Gulack BC; Meza JM; Lin SS; Hartwig MG; Davis RD
    Thorac Surg Clin; 2015; 25(1):97-105. PubMed ID: 25430433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib.
    Lam LH; Capparelli EV; Kurzrock R
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):427-32. PubMed ID: 27372908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients.
    Kofler S; Wolf C; Shvets N; Sisic Z; Müller T; Behr J; Sohn HY; Vogeser M; Shipkova M; Meiser B; Steinbeck G; Reichart B; Kaczmarek I
    J Heart Lung Transplant; 2011 May; 30(5):565-71. PubMed ID: 21256049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study.
    Knobbe TJ; Kremer D; Douwes RM; Eisenga MF; Gomes-Neto AW; Annema C; Swarte JC; Klont F; Navis G; Berger SP; Bakker SJL;
    Am J Kidney Dis; 2023 Aug; 82(2):189-201.e1. PubMed ID: 36801431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immunity influences long-term outcomes after human lung transplant.
    Palmer SM; Burch LH; Trindade AJ; Davis RD; Herczyk WF; Reinsmoen NL; Schwartz DA
    Am J Respir Crit Care Med; 2005 Apr; 171(7):780-5. PubMed ID: 15640363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-Lung transplant reflux testing demonstrates high prevalence of gastroesophageal reflux in cystic fibrosis and reduces chronic rejection risk.
    Lo WK; Flanagan R; Sharma N; Goldberg HJ; Chan WW
    World J Transplant; 2023 Jun; 13(4):138-146. PubMed ID: 37388387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of innate immunity in acute allograft rejection after lung transplantation.
    Palmer SM; Burch LH; Davis RD; Herczyk WF; Howell DN; Reinsmoen NL; Schwartz DA
    Am J Respir Crit Care Med; 2003 Sep; 168(6):628-32. PubMed ID: 12773319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
    Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
    Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
    Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
    Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic and acid-suppression medications during early childhood are associated with obesity.
    Stark CM; Susi A; Emerick J; Nylund CM
    Gut; 2019 Jan; 68(1):62-69. PubMed ID: 30377188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.
    Cantu E; Appel JZ; Hartwig MG; Woreta H; Green C; Messier R; Palmer SM; Davis RD
    Ann Thorac Surg; 2004 Oct; 78(4):1142-51; discussion 1142-51. PubMed ID: 15464462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.
    Agbor-Enoh S; Wang Y; Tunc I; Jang MK; Davis A; De Vlaminck I; Luikart H; Shah PD; Timofte I; Brown AW; Marishta A; Bhatti K; Gorham S; Fideli U; Wylie J; Grimm D; Goodwin N; Yang Y; Patel K; Zhu J; Iacono A; Orens JB; Nathan SD; Marboe C; Berry GJ; Quake SR; Khush K; Valantine HA
    EBioMedicine; 2019 Feb; 40():541-553. PubMed ID: 30692045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.